DeNovo NT Natural Tissue Graft Stratified Knee Study
A Stratified, Post-Market Study of DeNovo NT for the Treatment of Femoral and Patellar Articular Cartilage Lesions of the Knee
Sponsor: Zimmer Orthobiologics, Inc.
A NA clinical study on Defect of Articular Cartilage and Knee Injuries, this trial is ongoing. The trial is conducted by Zimmer Orthobiologics, Inc. and has accumulated 7 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2022 — Jul 2024 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jan 2021 — Jan 2022 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Jan 2021 [monthly]
Active Not Recruiting NA
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Mar 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Zimmer Orthobiologics, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .